354 related articles for article (PubMed ID: 30309995)
1. Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil
Ehren R; Benz MR; Doetsch J; Fichtner A; Gellermann J; Haffner D; Höcker B; Hoyer PF; Kästner B; Kemper MJ; Konrad M; Luntz S; Querfeld U; Sander A; Toenshoff B; Weber LT;
BMJ Open; 2018 Oct; 8(10):e024882. PubMed ID: 30309995
[TBL] [Abstract][Full Text] [Related]
2. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM; Wong SC; Willis NS; Craig JC
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
[TBL] [Abstract][Full Text] [Related]
3. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
Geng HY; Ji LN; Chen CY; Tu J; Li HR; Bao R; Lin Y
Zhonghua Er Ke Za Zhi; 2018 Sep; 56(9):651-656. PubMed ID: 30180402
[No Abstract] [Full Text] [Related]
4. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
[TBL] [Abstract][Full Text] [Related]
5. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
[TBL] [Abstract][Full Text] [Related]
6. Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome: study protocol.
Lugani F; Angeletti A; Ravani P; Vivarelli M; Colucci M; Caridi G; Verrina E; Emma F; Ghiggeri GM
BMJ Open; 2021 Nov; 11(11):e052450. PubMed ID: 34845071
[TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
Basu B; Preussler S; Sander A; Mahapatra TKS; Schaefer F
BMC Nephrol; 2020 Nov; 21(1):520. PubMed ID: 33256621
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome.
Tellier S; Dallocchio A; Guigonis V; Saint-Marcoux F; Llanas B; Ichay L; Bandin F; Godron A; Morin D; Brochard K; Gandia P; Bouchet S; Marquet P; Decramer S; Harambat J
Clin J Am Soc Nephrol; 2016 Oct; 11(10):1777-1782. PubMed ID: 27445161
[TBL] [Abstract][Full Text] [Related]
10. Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome.
Zhao M; Chen X; Chen Y; Liu Z; Liu Y; Lu F; Zhang Y; Wang H
Nephrology (Carlton); 2003 Jun; 8(3):105-9. PubMed ID: 15012724
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.
Dehoux L; Hogan J; Dossier C; Fila M; Niel O; Maisin A; Macher MA; Kwon T; Baudouin V; Deschênes G
Pediatr Nephrol; 2016 Nov; 31(11):2095-101. PubMed ID: 27263020
[TBL] [Abstract][Full Text] [Related]
13. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
Veltkamp F; Khan DH; Reefman C; Veissi S; van Oers HA; Levtchenko E; Mathôt RAA; Florquin S; van Wijk JAE; Schreuder MF; Haverman L; Bouts AHM
BMJ Open; 2019 Aug; 9(8):e027011. PubMed ID: 31375606
[TBL] [Abstract][Full Text] [Related]
14. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
15. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[TBL] [Abstract][Full Text] [Related]
16. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Deeks JJ; Wheatley K; Ives NJ;
BMJ; 2019 May; 365():l1800. PubMed ID: 31335316
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S; Zamora I; Berbel O; Sanahuja MJ; Fuentes J; Simon J
Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
[TBL] [Abstract][Full Text] [Related]
18. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
Ogarek I; Szczęsny-Choruz E; Wierzchowska-Słowiaczek E; Kwinta-Rybicka J; Stec Z; Moczulska A; Wilkosz K; Drożdż D
Pol Merkur Lekarski; 2018 Apr; 44(262):192-195. PubMed ID: 29775447
[TBL] [Abstract][Full Text] [Related]
19. [Mycophenolate mofetil restores renal function and spares steroids during idiopathic nephrotic syndrome in children. A cohort study].
Cailliez M; Bruno D; Daniel L; Afaneti M; Bérard E; Sarles J; Tsimaratos M
Nephrol Ther; 2008 Feb; 4(1):15-20. PubMed ID: 18096455
[TBL] [Abstract][Full Text] [Related]
20. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B; Mao J; Shen H; Fu H; Wang J; Liu A; Gu W; Shu Q; Du L
Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
